Nrf2在治疗中的作用
Maryam Azadmanesh1, Tahereh Farkhondeh2, Mohammad Sadra Harifi-Mood2
1Division of Pharmacology and Toxicology, Department of Basic Sciences, Faculty of Veterinary Medicine, University of Shiraz, Shiraz, Iran.
Current molecular medicine
|October 1, 2024
概括
氧化压力有助于. 激活Nrf2通路,保护细胞免受氧化应激,显示控制发作和治疗的希望.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 氧化应激,即反应性氧/物种与中和能力之间的不平衡,与众多疾病有关.
- 是一种慢性神经系统疾病,影响着数百万人,其特点是经常性发作,并且与发作事件发生前后发生的氧化应激有关.
- 核因子红色素衍生的2相关因子2 (Nrf2) 是一个关键的转录因子,调节参与细胞防御氧化应激的基因.
研究的目的:
- 审查与治疗和控制的Nrf2通路相关的潜在治疗标.
- 探索激活Nrf2的化合物作为治疗的策略.
主要方法:
- 文献审查确定了具有潜在抗作用的Nrf2激活剂.
- 检查了研究这些激活剂在模型中的体外和体内研究的证据.
主要成果:
- 几种Nrf2激活剂,包括Berberis化物,pentoxifylline,lovastatin,progesterone和chrysin纳米颗粒,被确定为潜在的治疗剂.
- 临床前研究 (体外和体内) 在各种模型中证明了这些化合物的有希望的结果.
- 有证据表明,氧化应激在的病理生理学中起着重要作用.
结论:
- 激活Nrf2通路是控制的可行治疗策略.
- 通过向Nrf2通路,审查的化合物显示出开发为新型抗治疗的潜力.
相关概念视频
Arteries of the Lower Limbs
181
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
181
Antiepileptic Drugs: Glutamate Antagonists
292
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
292
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
266
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
266


